Close

Evercore ISI Downgrades Neurocrine Bio. (NBIX) to In Line

November 14, 2022 3:27 AM EST Send to a Friend
Evercore ISI analyst Josh Schimmer downgraded Neurocrine Bio. (NASDAQ: NBIX) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login